The Venture Codex Logo

The Venture Codex

Haemonetics Corporation

125 Summer Street, Boston, MA, 02110, United States

Overview

Blood processing technology specialist.

Founded

1971

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series D

Geographic focus

Ireland

Sector focus

Biotechnology
Consulting
Health Care
Medical
...

Investment portfolio

1rounds
NAMEDATESIZE
Vivasure Medical
Mar 2023Led
$32 MSeries D
Vivasure Medical
Mar 2023Led
$32 MSeries D
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Haemonetics Corporation: 1 funding rounds are recorded in the selected participation categories.All available history.
Haemonetics Corporation: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series C+10

Monthly Deal Activity

Haemonetics Corporation: 1 deals are recorded across 44 months.All available history.
Haemonetics Corporation: 1 deals are recorded across 44 months. All available history
MonthDeals
Mar '231
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Haemonetics Corporation: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Haemonetics Corporation: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

Haemonetics Corporation: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Haemonetics Corporation: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Haemonetics Corporation: Europe has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Haemonetics Corporation: Europe has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Europe1
Haemonetics Corporation: 7 co-investors are shown, with Enterprise Ireland sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Haemonetics Corporation: 7 co-investors are shown, with Enterprise Ireland sharing 1 recorded deals. All available history
Co-investorShared deals
Enterprise Ireland1
European Investment Bank1
Evonik Venture Capital1
Fountain Healthcare Partners1
LSP Health Economics Fund1
Orchestra BioMed1
Panakes Partners1

Investment Strategy

Haemonetics Corporation: Led accounts for 100% and participating for 0% of round participation.All available history.
Haemonetics Corporation: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Haemonetics Corporation: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Haemonetics Corporation: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Byron Selman

President, Global Markets

Christopher Lindop

CFO & EVP Business Development

Christopher Simon

President and Chief Executive Officer

David Fusco

EVP, Global Human Resources

Jack Latham

Founder

James D'Arecca

Executive Vice President & Chief Financial Officer

Juan Diaz Cartelle

Executive Medical Director

Michelle Basil

Executive Vice President, General Counsel

Ronald Gelbman

Member of the Board of Directors